Fortress Biotech Inc (FBIO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2019 | 09-2019 | 06-2019 | 03-2019 | 12-2018 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -101,660 | -68,705 | -43,735 | -16,255 | -141,936 |
| Depreciation Amortization | 7,975 | 5,843 | 3,676 | 1,718 | 4,478 |
| Accounts receivable | -8,141 | 111 | 2,144 | -2,524 | 2,260 |
| Other Working Capital | -4,841 | -2,529 | -3,962 | 3,072 | 5,736 |
| Other Operating Activity | 11,706 | -4,629 | -11,768 | -11,336 | 30,614 |
| Operating Cash Flow | $-94,961 | $-69,909 | $-53,645 | $-25,325 | $-98,848 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 17,604 | 12,604 | 12,604 | 12,560 | 18,398 |
| PPE Investments | -6,995 | -2,305 | -955 | -300 | -8,156 |
| Purchase Sale Intangibles | -2,400 | -2,400 | N/A | N/A | -1,200 |
| Other Investing Activity | 9,488 | 9,488 | 11,888 | 11,888 | 8,582 |
| Investing Cash Flow | $20,097 | $19,787 | $23,537 | $24,148 | $18,824 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 15,000 | 15,000 | 15,000 | 15,000 | N/A |
| Debt Issued | N/A | N/A | N/A | N/A | 21,707 |
| Common Stock Issued | 106,983 | 66,683 | 66,683 | 34,999 | 23,390 |
| Dividend Paid | -2,559 | -1,773 | -1,172 | -586 | -2,344 |
| Other Financing Activity | 27,290 | 39,649 | 33,496 | 2,700 | 7,895 |
| Financing Cash Flow | $146,714 | $119,559 | $114,007 | $52,113 | $50,648 |
| Beginning Cash Position | 81,582 | 81,582 | 81,582 | 81,582 | 110,958 |
| End Cash Position | 153,432 | 151,019 | 165,481 | 132,518 | 81,582 |
| Net Cash Flow | $71,850 | $69,437 | $83,899 | $50,936 | $-29,376 |
| Free Cash Flow | |||||
| Operating Cash Flow | -94,961 | -69,909 | -53,645 | -25,325 | -98,848 |
| Capital Expenditure | -6,995 | -2,305 | -955 | -300 | -8,156 |
| Free Cash Flow | -101,956 | -72,214 | -54,600 | -25,625 | -107,004 |